Back to results
US 8,076,358 B2Granted
6-substituted-thio-2-amino-quinoline derivatives useful as inhibitors of β-secretase (BACE)
AssigneeJanssen Pharmaceutica NV
InventorsEllen Baxter, Christopher J. Creighton, Tianbao Lu, Allen B. Reitz, Charles H. Reynolds, Tina Morgan Ross, Ellen Sieber-McMaster
Life of this patent
Estimating the term…
Abstract
The present invention is directed to 6-substituted-thio-2-amino-quinoline derivatives, pharmaceutical compositions containing them and their use in the treatment of Alzheimer's disease (AD), mild cognitive impairment, senility and/or dementia. The compounds of the present invention are inhibitors of β-secretase, also known as β-site amyloid cleaving enzyme, BACE, BACE1, Asp2, or memapsin2.
Claims13
A compound of formula (I)
- wherein
- R1 is selected from the group consisting of C1-4alkyl, C3-8cycloalkyl, 5-6 membered heteroaryl, —(C1-4alkyl)-(5-6 membered heteroaryl), 5-6 membered heterocycloalkyl and —(C1-4alkyl)-5-6 membered heterocycloalkyl;
- R2 is selected from the group consisting of hydrogen and halogen;
- L1 is selected from the group consisting of —CH2—NRA—, —CH2CH2—NRA, —CH2—O— and —CH2—S—;
- wherein RA is selected from the group consisting of hydrogen, C1-4alkyl, —C(O)—C1-4alkyl, —C(O)O—C1-4alkyl and —SO2—C1-4alkyl;
- R3 is selected from the group consisting of C1-4alkyl, carboxy substituted C1-4alkyl, C4-8cycloalkyl, —(C1-4alkyl)-C4-8cycloalkyl, partially unsaturated carbocyclyl, —(C1-4alkyl)-(partially unsaturated carbocyclyl), aryl, —(C1-4alkyl)-aryl, heteroaryl, —(C1-4alkyl)-heteroaryl, heterocycloalkyl and —(C1-4alkyl)-heterocycloalkyl;
- wherein the C4-8cycloalkyl, aryl, heteroaryl or heterocycloalkyl, whether alone or as part of a substituent group is optionally substituted with one or more substituents independently selected from the group consisting of halogen, hydroxy, carboxy, C1-4alkyl, fluorinated C1-4alkyl, —C1-4alkoxy-, fluorinated —C1-4alkoxy, —C1-4alkyl-OH, —C1-4alkyl-CO2H and phenyl;
- alternatively, RA and R3 are taken together with the nitrogen atom to which they are bound to form a ring selected from the group consisting of 5 to 6 membered heteroaryl and 5 to 6 membered heterocycloalkyl;
- or a pharmaceutically acceptable salt thereof.
6 more elements
A compound selected from the group consisting of a compound of formula (II-a)
- or a pharmaceutically acceptable salt thereof;
- and a compound of formula (II-b)
- or pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.